Non-Small Cell Lung Cancer Market – Industry Insights, Size, Share and Analysis, 2018-2026

Non-Small Cell Lung Cancer Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND
OPPORTUNITY ANALYSIS, 2018-2026
REPORT DESCRIPTION
Non-Small Cell Lung Cancer Market – Overview
Cancer is the disease in which cell grows abnormally and may cause a tumor. In lung cancer, the cells of lungs
starts to grow in uncontrolled manner later form a tumor and can be spread into other body parts. Small cell lung
cancer and non-small cell lung cancer are the two main types of lung cancer. As per the stats of Lung Cancer
Alliance (leading nonprofit organization dedicated to fighting lung cancer), out of overall lung cancer, around 80
to 85% cases found are of non-small cell lung cancer type and 15-20% cases found are of small cell lung cancer
type.
The different, commonly diagnosed types of non-small cell lung cancer (NSCLC) are adenocarcinoma, squamous
cell carcinoma, large cell carcinoma, large cell neuroendocrine tumors. Out of all these types adenocarcinoma and
squamous cell carcinoma accounts around 60% of lung cancer.
Some diagnosis test are performed by doctors to detect the lung cancer includes diagnostic imaging test like Xray, MRI, Ultrasound, CT scan and PET scan, also by checking the mucous when the patient cough up for cancer
cells which is called as sputum cytology or also by taking the cells of your lungs from abnormal growth area of
your lung or from the fluid of lungs which is called as fine needle aspiration biopsy, bronchoscopy and
Mediastinoscopy.
REPORT DESCRIPTION
Non-Small Cell Lung Cancer Market Taxonomy:
Global NSCLC Market by Type of NSCLC
Adenocarcinoma
Squamous cell carcinoma
Large cell carcinoma
Large cell neuroendocrine tumors
Global NSCLC Market by Type of Treatment
Surgery
Chemotherapy
Targeted therapy
Radiation therapy
Get Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/241
REPORT DESCRIPTION
Non-Small Cell Lung Cancer Market – Key Players
AstraZeneca Plc
F. Hoffmann-La Roche Ltd
Eli Lilly and Company
Agennix AG
ArQule Inc
GlaxoSmithKline Pharmaceuticals Limited
Daiichi Sankyo Co. Ltd
Sanofi-Aventis
Boehringer Ingelheim GmbH. Also as per U.S. Food and Drug Administration some latest drug approvals
in Market of non-small cell lung cancer by USFDA are on October 24, 2016 pembrolizumab (Merck &
Co., Inc.) received approval, also FDA approved atezolizumab for the treatment of NSCLC on October 18,
2016.
Get More Inf @
https://www.coherentmarketinsights.com/ongoing-insight/non-small-cell-lung-cancer-market-241
ABOUT COHERENT MARKET INSIGHTS
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its
plethora of clients achieve transformational growth by helping them make critical business decisions. We are
headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players
from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various recommendations about
operational improvements, technologies, emerging market trends and new working methods. We offer both
customized and syndicated market research reports that help our clients create visionary growth plans to
provide traction to their business. We meticulously study emerging trends across various industries at both the
global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
MARKET INTELLIGENCE SERVICES
CUSTOMIZED RESEARCH
CONSULT STUDIES
SYNDICATED RESEARCH
COUNTRY SPECIFIC STUDIES
ABOUT CMI
SECTOR
COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS







Global Leading Equipment and System Manufacturers
Component Providers and System Integrators
Distributors, Retailors and Value Added Resellers
Healthcare IT Solutions Developers
Marketing Consultancies and the Advertising Industry
Private and Government organization
Outsourcing Companies
ABOUT US
KEY STATS
RESEARCH
SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare,
and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports
across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique
—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our
clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities
posed therein.
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
[email protected]
+1-206-701-6702

Cancer is the disease in which cell grows abnormally and may cause a tumor.